首页> 外文期刊>Annals of surgical oncology >High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?
【24h】

High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?

机译:对上消化道癌新辅助治疗的高度毒性:对围手术期和肿瘤学结局有何影响?

获取原文
获取原文并翻译 | 示例

摘要

Perioperative oncologic treatments provide a survival benefit for junctional and gastric adenocarcinoma (JGA) and esophageal cancer (EC). Whether neoadjuvant therapy toxicity (NTT) correlates with increased perioperative risk remains unclear. We aimed to evaluate the impact of grade III/IV NTT on postoperative and oncologic outcomes in resected upper gastrointestinal malignancies.
机译:围手术期肿瘤治疗为结节和胃腺癌(JGA)和食道癌(EC)提供了生存获益。目前尚不清楚新辅助治疗毒性(NTT)是否与围手术期风险增加相关。我们旨在评估III / IV级NTT对切除的上消化道恶性肿瘤术后和肿瘤学结局的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号